Literature DB >> 15115125

In vitro susceptibility of Plasmodium falciparum isolates to chloroquine and mefloquine in southeastern Mindanao Island, the Philippines.

Toshimitsu Hatabu1, Shin-ichiro Kawazu, Jun Suzuki, Reuben F Valenzuela, Elena A Villacorte, Mamoru Suzuki, Pilarita T Rivera, Shigeyuki Kano.   

Abstract

Although the presence of multi-drug-resistant falciparum malaria has been reported in the Philippines, the distribution of drug-resistant malaria parasites has not yet been determined in Mindanao Island. In vitro susceptibility of P. falciparum to both chloroquine and mefloquine was assessed to forecast the spread of drug-resistant parasites in various foci in southeastern Mindanao Island. Of the 33 isolates of P. falciparum successfully tested, 10 (30%) were susceptible, 12 (36%) showed decreased susceptibility (80 nM < or = IC50 < 114 nM), and 11 (33%) were resistant (IC50 > or = 114 nM) to chloroquine. Ten (91%) of the resistant isolates and 9 (75%) of those with decreased susceptibility were from northern and northwestern Davao del Norte Province. Chloroquine-susceptible isolates were found among patients in the eastern parts of Davao del Norte and Davao Oriental provinces. Seven isolates from several foci in the study area were all mefloquine- susceptible (IC50 < 10 nM). This is the first report indicating the potential emergence of chloroquine-resistant P. falciparum on Mindanao Island, which is presently regarded as a drug-susceptible area.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15115125

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  1 in total

1.  Genetic diversity and population structure of Plasmodium falciparum in the Philippines.

Authors:  Moritoshi Iwagami; Pilarita T Rivera; Elena A Villacorte; Aleyla D Escueta; Toshimitsu Hatabu; Shin-ichiro Kawazu; Toshiyuki Hayakawa; Kazuyuki Tanabe; Shigeyuki Kano
Journal:  Malar J       Date:  2009-05-08       Impact factor: 2.979

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.